CAPREOMYCIN SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for capreomycin sulfate and what is the scope of freedom to operate?
Capreomycin sulfate
is the generic ingredient in two branded drugs marketed by Epic Pharma Llc, Hisun Pharm Hangzhou, and Norvium Bioscience, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for capreomycin sulfate.
Summary for CAPREOMYCIN SULFATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 1 |
| Patent Applications: | 1 |
| DailyMed Link: | CAPREOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for CAPREOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
Medical Subject Heading (MeSH) Categories for CAPREOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for CAPREOMYCIN SULFATE
US Patents and Regulatory Information for CAPREOMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisun Pharm Hangzhou | CAPREOMYCIN SULFATE | capreomycin sulfate | INJECTABLE;INJECTION | 204796-001 | Oct 18, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | CAPREOMYCIN SULFATE | capreomycin sulfate | INJECTABLE;INJECTION | 202634-001 | Nov 27, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | CAPASTAT SULFATE | capreomycin sulfate | INJECTABLE;INJECTION | 050095-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
